Xuejun Xia

1.2k total citations
41 papers, 926 citations indexed

About

Xuejun Xia is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Xuejun Xia has authored 41 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Pharmaceutical Science and 11 papers in Biomaterials. Recurrent topics in Xuejun Xia's work include RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (10 papers) and Advancements in Transdermal Drug Delivery (10 papers). Xuejun Xia is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (10 papers) and Advancements in Transdermal Drug Delivery (10 papers). Xuejun Xia collaborates with scholars based in China and Czechia. Xuejun Xia's co-authors include Yuling Liu, Wujun Dong, Yanfang Yang, Jun Ye, Cuiping Zhou, Yuling Liu, Hongliang Wang, Liyao Liu, Panpan Ma and Lin Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Journal of Controlled Release.

In The Last Decade

Xuejun Xia

40 papers receiving 911 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuejun Xia China 21 386 258 222 172 86 41 926
Minyan Wei China 18 467 1.2× 234 0.9× 295 1.3× 194 1.1× 64 0.7× 38 1.2k
Md Habban Akhter India 21 364 0.9× 358 1.4× 361 1.6× 270 1.6× 96 1.1× 42 1.2k
M. Luísa Corvo Portugal 24 591 1.5× 356 1.4× 218 1.0× 246 1.4× 81 0.9× 59 1.5k
Jong-Suep Baek South Korea 17 325 0.8× 276 1.1× 463 2.1× 128 0.7× 83 1.0× 40 945
Rajendra Kumar India 20 293 0.8× 229 0.9× 224 1.0× 189 1.1× 168 2.0× 60 1.1k
Siddharth S. Kesharwani United States 18 384 1.0× 308 1.2× 123 0.6× 222 1.3× 148 1.7× 30 1.1k
Subramanian Natesan India 19 302 0.8× 247 1.0× 421 1.9× 181 1.1× 61 0.7× 52 1.1k
Kalvatala Sudhakar India 16 433 1.1× 176 0.7× 305 1.4× 125 0.7× 61 0.7× 38 1.2k
Mohamed Rahamathulla Saudi Arabia 18 261 0.7× 256 1.0× 297 1.3× 255 1.5× 61 0.7× 66 1.1k
Hemachand Tummala United States 19 341 0.9× 176 0.7× 114 0.5× 111 0.6× 96 1.1× 31 935

Countries citing papers authored by Xuejun Xia

Since Specialization
Citations

This map shows the geographic impact of Xuejun Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejun Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejun Xia more than expected).

Fields of papers citing papers by Xuejun Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuejun Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejun Xia. The network helps show where Xuejun Xia may publish in the future.

Co-authorship network of co-authors of Xuejun Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Xuejun Xia. A scholar is included among the top collaborators of Xuejun Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuejun Xia. Xuejun Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hongliang, Jinping Hu, Ming Ji, et al.. (2024). Drug-like properties of serial phenanthroindolizidine alkaloid compounds: ADMET characteristic prediction and validation. SHILAP Revista de lepidopterología. 3(1). 2 indexed citations
2.
Meng, Yingying, et al.. (2024). Breath and Beyond: Advances in Nanomedicine for Oral and Intranasal Aerosol Drug Delivery. Pharmaceuticals. 17(12). 1742–1742. 3 indexed citations
3.
Yang, Yuqi, You Xu, Yingying Meng, et al.. (2022). Deformable Nanovesicle-Loaded Gel for Buccal Insulin Delivery. Pharmaceutics. 14(11). 2262–2262. 5 indexed citations
4.
Ye, Jun, Lin Li, Ji‐Ye Yin, et al.. (2022). Tumor-targeting intravenous lipid emulsion of paclitaxel: Characteristics, stability, toxicity, and toxicokinetics. Journal of Pharmaceutical Analysis. 12(6). 901–912. 14 indexed citations
5.
Wang, Hongliang, Lin Li, Jun Ye, et al.. (2021). Improved Safety and Anti-Glioblastoma Efficacy of CAT3-Encapsulated SMEDDS through Metabolism Modification. Molecules. 26(2). 484–484. 6 indexed citations
6.
Li, Lian, Wujun Dong, Xiangyang Zhu, et al.. (2021). Research on Transfer Rate of Heavy Metals and Harmful Elements in Traditional Chinese Medicine Extraction and Refining Processes and Product Health Risk Assessment. Biological Trace Element Research. 200(4). 1956–1964. 9 indexed citations
7.
Wang, Hongliang, Li Lin, Jun Ye, et al.. (2020). Improving the Oral Bioavailability of an Anti-Glioma Prodrug CAT3 Using Novel Solid Lipid Nanoparticles Containing Oleic Acid-CAT3 Conjugates. Pharmaceutics. 12(2). 126–126. 25 indexed citations
8.
Ye, Jun, Yanfang Yang, Wujun Dong, et al.. (2019). <p>Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages</p>. International Journal of Nanomedicine. Volume 14. 3203–3220. 66 indexed citations
9.
Yang, Yanfang, Yingying Meng, Jun Ye, et al.. (2018). Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angiogenesis, and tumor cell apoptosis procedurally via a multi-functional polymer micelle. Journal of Controlled Release. 287. 103–120. 37 indexed citations
10.
11.
Ye, Jun, Wujun Dong, Yanfang Yang, et al.. (2017). Vitamin E-rich Nanoemulsion Enhances the Antitumor Efficacy of Low-Dose Paclitaxel by Driving Th1 Immune Response. Pharmaceutical Research. 34(6). 1244–1254. 21 indexed citations
12.
Yang, Yanfang, Xiangyang Xie, Xueqing Xu, et al.. (2016). Thermal and magnetic dual-responsive liposomes with a cell-penetrating peptide-siRNA conjugate for enhanced and targeted cancer therapy. Colloids and Surfaces B Biointerfaces. 146. 607–615. 45 indexed citations
13.
Ye, Jun, Yuling Liu, Xuejun Xia, et al.. (2016). Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors. Oncology Reports. 36(1). 399–409. 23 indexed citations
14.
Yang, Yanfang, Xuejun Xia, Wujun Dong, et al.. (2016). Acid Sensitive Polymeric Micelles Combining Folate and Bioreducible Conjugate for Specific Intracellular siRNA Delivery. Macromolecular Bioscience. 16(5). 759–773. 16 indexed citations
15.
Yang, Yanfang, Yang� Yang, Xiangyang Xie, et al.. (2016). Dual stimulus of hyperthermia and intracellular redox environment triggered release of siRNA for tumor-specific therapy. International Journal of Pharmaceutics. 506(1-2). 158–173. 25 indexed citations
16.
Xia, Xuejun, Yanfang Yang, Jun Ye, et al.. (2016). Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition. International Journal of Pharmaceutics. 513(1-2). 8–16. 87 indexed citations
17.
Ye, Jun, Xuejun Xia, Wujun Dong, et al.. (2016). Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel&ndash;cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines. International Journal of Nanomedicine. Volume 11. 4125–4140. 33 indexed citations
18.
Xia, Xuejun, Xiaowei Song, Jiaming Xu, et al.. (2015). Development of a validated LC–APCI-MS/MS method to study the plasma and tumor distribution of CHO-PTX intravenous lipid emulsion. Journal of Pharmaceutical and Biomedical Analysis. 117. 532–543. 3 indexed citations
19.
Yang, Shuang, Baolian Wang, Xuejun Xia, et al.. (2015). Simultaneous quantification of three active alkaloids from a traditional Chinese medicine Ramulus Mori (Sangzhi) in rat plasma using liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 109. 177–183. 34 indexed citations
20.
Ma, Yanli, et al.. (2013). [Comparative study on pharmacokinetics and tissue distribution of a novel microemulsion based on the paclitaxel/L-OH lipid complex and paclitaxel injection in cremophor].. PubMed. 48(11). 1698–704. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minyan Wei Breakdown of academic impact, for papers by Md Habban Akhter Breakdown of academic impact, for papers by M. Luísa Corvo Breakdown of academic impact, for papers by Jong-Suep Baek Breakdown of academic impact, for papers by Rajendra Kumar Breakdown of academic impact, for papers by Siddharth S. Kesharwani Breakdown of academic impact, for papers by Subramanian Natesan Breakdown of academic impact, for papers by Kalvatala Sudhakar Breakdown of academic impact, for papers by Mohamed Rahamathulla Breakdown of academic impact, for papers by Hemachand Tummala
Rankless by CCL
2026